US$ 28.05
glp-1 weight loss drug news today drugs leave users low on key nutrients, study finds GLP-1 Weight-Loss Drugs Could Address
Description
Ozempic is FDA-approved for type 2 diabetes at doses up to 2.0mg weekly, while Wegovy is specifically approved for chronic weight management at the higher 2.4mg dose

October 2, 2023

The New England Journal of Medicine

First, we did not require patients to continuously take a GLP-1 RA for a pre-specified amount of time before discontinuation
